Abstract Alpha-foetoprotein (AFP), one of the first protein tumour markers discovered, is
widely used today in clinical practice. Its application for the screening and diagnosis of …

Microvascular invasion (MVI) in hepatocellular carcinoma (HCC) is an independent
predictor of poor outcomes subsequent to surgical resection or liver transplantation (LT); …

Objectives To develop and validate a radiomics nomogram for preoperative prediction of
microvascular invasion (MVI) in patients with hepatocellular carcinoma (HCC). Methods The …

Background We aimed to develop and validate a nomogram combining bi-regional
radiomics features from multimodal magnetic resonance imaging (MRI) and …

Liquid biopsies hold tremendous promise in pediatric oncology, enabling noninvasive serial
surveillance with adaptive care. Already integrated into adult care, recent advances in …

Background There is currently no established model for predicting the recurrence of
hepatocellular carcinoma (HCC) in patients with negative alpha‐fetoprotein (AFP) after …

Background: Tumor markers are used to screen tens of millions of individuals worldwide at
annual health check-ups, especially in East Asia. Machine learning (ML)-based algorithms …

Background To investigate the prognostic values of the change of α-fetoprotein within 1
week after resection of hepatocellular carcinoma. Methods We retrospectively analyzed …

Background and study aims The relationship between the alpha-fetoprotein (AFP) level and
the prognosis of hepatocellular carcinoma (HCC) after surgical resection remains unknown …

Background Alpha-fetoprotein (AFP) is useful as a tumor marker for sacrococcygeal
teratoma (SCT). We investigated the half-life of AFP in SCT. Methods Neonates who …